Nordic Center for Sustainable Healthcare

    A network under TEM •  • +46 (0) 406 06 55 80 • Contact us

    New Member: Addax Biosciences

    NCSH's members cross borders of innovation, sectors as well as countries!

    Our newest member is no exception to the rule: We are happy to be introducing Addax Biosciences from Italy to the network. In their own words, they describe their ambitious work for greener care practices like this:

    "At Addax Biosciences, we believe in making the healthcare system sustainable, accessible, and resilient. The aim to ensure the population's health and long-term care starts with the relationship between environmental issues, their economic impact, and their social effects.

    At Addax Biosciences, we aim to substitute Formalin (a solution based on Formaldehyde) from hospitals, research centres and laboratories.

    Formaldehyde is a carcinogenic, mutagenic, and neurotoxic substance. Although its use has
    been severely restricted in Europe (Reg. 2014/895, Reg. 2018/675, Dir. 2019/983), it is still widely used as a histological fixative in hospitals in the absence of a viable and safe alternative.

    Addax Biosciences was born at the end of 2017 as a spinoff of the University of Turin after extensive research on histological fixation in anatomical pathology.

    Addax Biosciences has developed and patented GAF®, an innovative formalin-free, non-carcinogenic product that offers fixation efficiency comparable to Formalin for biopsies processing.

    We are committed to providing diagnostic accuracy without exposing healthcare personnel to the risk of occupational disease. With several independent multicentric trials, GAF® diagnostic efficacy has been internationally recognized and validated.

    Social Impact
    At Addax Biosciences, we believe that sustainability also means moving the focus from short-term saving to long-term efficiency through a systemic evaluation of the performance within the healthcare system. We are committed to promoting innovation to develop safer, more sustainable alternatives and a vision for a non-toxic environment.

    IARC, the International Agency for Research on Cancer, classifies Formaldehyde as a category one carcinogen ("recognized carcinogen"), similar to asbestos. Almost 1.000.000 medical operators in the EU are exposed daily to Formaldehyde, with a 5-fold higher risk of cancer.

    Avoiding exposure of healthcare professionals to carcinogenic formaldehyde vapours while ensuring valuable diagnosis for the patients is now possible through GAF® adoption.

    At Addax Biosciences, we do realize changes are always a big challenge. However, we firmly believe evolution is essential for society. We are committed to providing our clients the best tools to participate in this change."

    Interested in learning more and getting in touch with Addax Biosciences? Visit their website:

    Not yet a member in NCSH? Simply click the button to join:

    Become a member

    Our news

    Contact us!

    Our office is located in Malmö, but the NCSH spans over Scandinavia, Northern Europe and beyond.
    Сontact us if you want to learn more about the NCSH:

    Nordic Center for
    Sustainable Healthcare
    C/O TEM
    Södra Promenaden 51
    211 38 Malmö

    Phone: +46 (0)40-606 55 80

    Detailed contact information


    Eager to know more about the Nordic Center for Sustainable Healthcare
    and what we can offer you?

    Contact us:

    Phone: + 46 (0) 40 606 55 80

    NCSH logoTEM logo

    © 2023 Nordic Center for Sustainable Healthcare
    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.